|
Aspartate-Semialdehyde Dehydrogenase
|
D08.811.682.657.163.374 |
|
|
Pronase
|
D08.811.277.656.300.760.638 |
|
|
Calbindin 2
|
D12.776.157.125.090.249 |
|
|
Calbindins
|
D12.776.157.125.090 |
|
|
Elongation Factor 2 Kinase
|
D12.776.476.100.425 |
|
|
Nairobi Sheep Disease
|
C01.920.930.550 |
|
|
Cerebral Ventriculitis
|
C10.228.140.430.249 |
|
|
Pedobacter
|
B03.440.080.600 |
|
|
Employee Performance Appraisal
|
N04.452.677.370 |
|
|
Zalcitabine
|
D03.383.742.680.245.500.950 |
|
|
Plasminogen Activators
|
D08.811.277.656.300.760.635 |
|
|
Prolyl Oligopeptidases
|
D08.811.277.656.300.760.637 |
|
|
Building Codes
|
N02.278.200.100 |
|
|
Facility Design and Construction
|
N02.278.200 |
|
|
Receptors, FSH
|
D12.776.543.750.750.660.350.300 |
|
|
Arm Bones
|
D050280 |
[The bones of the free part of the upper extremity including the HUMERUS; RADIUS; and ULNA.
] |
|
Genome-Wide Association Study
|
N06.850.520.445.392 |
|
|
Bones of Lower Extremity
|
D050281 |
[The bones of the upper and lower LEG. They include the PELVIC BONES.
] |
|
Phosphinic Acids
|
D02.705.629 |
|
|
Optic Atrophy, Autosomal Dominant
|
C11.270.564.100 |
|
